Medline $MDLN Shares Bought by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. increased its position in shares of Medline (NASDAQ:MDLN) by 330.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 100,000 shares of the company’s stock after buying an additional 76,761 shares during the period. Jefferies Financial Group Inc.’s holdings in Medline were worth $3,470,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Janus Henderson Group PLC lifted its stake in Medline by 8.4% in the first quarter. Janus Henderson Group PLC now owns 11,451,861 shares of the company’s stock valued at $506,546,000 after buying an additional 887,240 shares during the period. Banque Pictet & Cie SA grew its position in shares of Medline by 2.0% during the 3rd quarter. Banque Pictet & Cie SA now owns 7,455,089 shares of the company’s stock worth $258,692,000 after buying an additional 142,939 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of Medline by 233.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 5,000,000 shares of the company’s stock worth $222,500,000 after buying an additional 3,500,000 shares during the period. Bessemer Group Inc. increased its stake in shares of Medline by 39,404.0% in the 1st quarter. Bessemer Group Inc. now owns 3,504,006 shares of the company’s stock valued at $155,929,000 after acquiring an additional 3,495,136 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Medline by 30,255.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,700,425 shares of the company’s stock valued at $94,353,000 after acquiring an additional 2,691,529 shares during the period.

Medline Price Performance

Shares of NASDAQ:MDLN opened at $39.98 on Friday. The company has a market capitalization of $52.56 billion and a P/E ratio of 34.84. The company’s 50-day moving average is $35.22 and its 200 day moving average is $39.40. The company has a debt-to-equity ratio of 0.65, a quick ratio of 2.51 and a current ratio of 4.04. Medline has a fifty-two week low of $31.37 and a fifty-two week high of $50.88.

Medline (NASDAQ:MDLN) last issued its earnings results on Wednesday, November 4th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.12. Medline had a return on equity of 8.21% and a net margin of 1.84%. The firm had revenue of $7.86 billion for the quarter. On average, equities research analysts forecast that Medline will post 1.58 earnings per share for the current year.

Analyst Ratings Changes

MDLN has been the topic of several recent research reports. JPMorgan Chase & Co. cut their price target on Medline from $53.00 to $46.00 and set an “overweight” rating on the stock in a report on Wednesday, August 12th. Evercore set a $39.00 price objective on Medline in a report on Thursday, August 6th. Barclays lowered their target price on Medline from $45.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, October 9th. Stifel Nicolaus cut their target price on Medline from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Finally, Mizuho cut their target price on Medline from $48.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, October 22nd. Twenty-three investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $46.08.

Insider Buying and Selling

In other Medline news, major shareholder Private Ltd Gic sold 2,570,999 shares of Medline stock in a transaction dated Friday, October 2nd. The stock was sold at an average price of $35.35, for a total transaction of $90,884,814.65. Following the completion of the transaction, the insider owned 20,231,483 shares of the company’s stock, valued at $715,182,924.05. The trade was a 11.28% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In the last ninety days, insiders sold 6,348,676 shares of company stock valued at $224,525,137. 0.81% of the stock is owned by company insiders.

Medline Company Profile

Medline is a healthcare products manufacturer and distributor serving providers across the care continuum. Its customers include hospitals, surgery centers, physician practices, long-term care facilities and home-care organizations. The company offers a broad range of medical and surgical supplies, including products for infection prevention, wound care and patient care, as well as apparel and equipment. Medline also provides supply-chain and logistics services to healthcare organizations. Founded in 1966, Medline is headquartered in Northfield, Illinois, and serves customers in the United States and internationally.